Compare Immunovant Inc. Common Stock (IMVT) vs NOV Inc. Common Stock (NOV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs NOV Inc. Common Stock — how do they compare? Immunovant Inc. Common Stock trades at $30.5 (market cap $6.25B), while NOV Inc. Common Stock trades at $18.97 (market cap $6.77B). The key difference: Immunovant Inc. Common Stock and NOV Inc. Common Stock are close in size by market cap, and NOV Inc. Common Stock pays a 1.9% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 1 Days and NOV Inc. Common Stock for 1 Days on average.
| IMVT | NOV | |
|---|---|---|
Market Cap | $6.25B | $6.77B |
Volume | 1,755,411 | 3,592,724 |
Sector | Health | Energy |
52-Week High | $44.96 | $21.71 |
52-Week Low | $17.03 | $12.31 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $5.35B | $7.93B |
Dividend Yield | — | 1.9% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About NOV Inc. Common Stock
NOV provides technology, equipment, and services for energy production. Its offerings support drilling, well construction, and production across oil, gas, renewables, and emerging energy markets.
Read more on NOV →
